Importantly, analogous PEMF exposure of breast cancer cells potentiated the anti-cancer effects of DOX in vitro, ex vivo and in vivo, revealing a synergistic relationship between PEMFs, TRPC1 expression and DOX treatment [22]. The gene discussed is TRPC1; the disease is breast cancer.